We are live on
!
Find out more
NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.45B
Turnover
15.82%
1-Year Est. Return
28.39%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$273M
AUM Growth
+$15.1M
(+5.8%)
Cap. Flow
+$6.65M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
31.31%
Holding
136
New
8
Increased
56
Reduced
24
Closed
12
Avg Time Held Equity + Options
1.4
years
Top 10 Avg Time Held Equity + Options
0.9
years
Top 20 Avg Time Held Equity + Options
1.2
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.97M |
| 2 |
Exelon
EXC
|
+$1.99M |
| 3 |
Prudential Financial
PRU
|
+$1.48M |
| 4 |
American Express
AXP
|
+$1.24M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.73M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$1.68M |
| 3 |
NextEra Energy
NEE
|
+$1.14M |
| 4 |
BHP
BHP
|
+$1.04M |
| 5 |
BP
BP
|
+$996K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 13.82% |
| 2 | Miscellaneous | 12.91% |
| 3 | Healthcare | 12.42% |
| 4 | Financials | 11.83% |
| 5 | Technology | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Vulcan Materials
VMC
$32.6B
| $36M | 13.16% |
426,973
+300
| +0.1% | +$23.2K |
2013 Q2
7 quarters
|
|
2
Apple
AAPL
$5T
| $9.31M | 3.4% |
299,180
+3,360
| +1% | +$101K |
2013 Q2
7 quarters
|
|
3
GE Aerospace
GE
$322B
| $5.94M | 2.17% |
49,954
+290
| +0.6% | +$34.5K |
2013 Q2
7 quarters
|
|
4
Alphabet (Google) Class C
GOOG
$4.22T
| $5.9M | 2.16% |
215,931
+9,867
| +5% | +$264K |
2014 Q2
3 quarters
|
|
5
Microsoft
MSFT
$4.01T
| $5.7M | 2.09% |
140,260
+1,115
| +0.8% | +$48.5K |
2013 Q2
7 quarters
|
|
6
JPMorgan Chase
JPM
$887B
| $5.12M | 1.87% |
84,500
+550
| +0.7% | +$32.6K |
2013 Q2
7 quarters
|
|
7
iShares Core S&P 500 ETF
IVV
$888B
| $4.67M | 1.71% |
22,467
-2,380
| -10% | -$495K |
2013 Q2
7 quarters
|
|
8
General Dynamics
GD
$91.1B
| $4.46M | 1.63% |
32,896
| – | – |
2013 Q2
7 quarters
|
|
9
Pfizer
PFE
$169B
| $4.3M | 1.57% |
130,285
| – | – |
2013 Q2
7 quarters
|
|
10
ExxonMobil
XOM
$719B
| $4.21M | 1.54% |
49,476
+6,115
| +14% | +$542K |
2013 Q2
7 quarters
|
|
11
Verizon
VZ
$185B
| $4.12M | 1.51% |
84,775
+1,755
| +2% | +$84.7K |
2014 Q1
4 quarters
|
|
12
American International
AIG
$41.5B
| $4.1M | 1.5% |
74,774
+690
| +0.9% | +$37K |
2013 Q2
7 quarters
|
|
13
SPDR Gold Trust
GLD
$141B
| $4M | 1.46% |
35,215
+875
| +3% | +$102K |
2013 Q2
7 quarters
|
|
14
Johnson & Johnson
JNJ
$610B
| $3.95M | 1.44% |
39,236
-1,045
| -3% | -$106K |
2013 Q2
7 quarters
|
|
15
Intel
INTC
$497B
| $3.75M | 1.37% |
119,753
+175
| +0.1% | +$5.91K |
2013 Q2
7 quarters
|
|
|
RTN
16
DELISTED
Raytheon Company
RTN
| $3.58M | 1.31% |
32,805
| – | – |
2013 Q2
7 quarters
|
|
17
Northrop Grumman
NOC
$70.8B
| $3.56M | 1.3% |
22,150
-430
| -2% | -$68.7K |
2013 Q2
7 quarters
|
|
18
Citigroup
C
$206B
| $3.53M | 1.29% |
68,525
+850
| +1% | +$43.3K |
2013 Q2
7 quarters
|
|
19
Goldman Sachs
GS
$258B
| $3.46M | 1.27% |
18,405
+5,000
| +37% | +$930K |
2013 Q2
7 quarters
|
|
20
Philip Morris
PM
$313B
| $3.42M | 1.25% |
45,455
+4,640
| +11% | +$377K |
2013 Q2
7 quarters
|
|
21
Elevance Health
ELV
$92.9B
| $3.42M | 1.25% |
22,125
| – | – |
2013 Q2
7 quarters
|
|
22
Comcast
CMCSA
$77B
| $3.29M | 1.21% |
116,700
+4,200
| +4% | +$121K |
2013 Q2
7 quarters
|
|
|
23
Exelon
EXC
$43.9B
| $3.21M | 1.17% |
133,961
+80,531
| +151% | +$1.99M |
2013 Q2
7 quarters
|
|
|
24
Medtronic
MDT
$122B
| $3.06M | 1.12% |
+39,175
| New | +$2.97M |
2015 Q1
0 quarters
|
|
25
HCA Healthcare
HCA
$102B
| $3.02M | 1.1% |
40,085
+2,425
| +6% | +$174K |
2013 Q4
5 quarters
|
|
Similar funds
NP
BFMH
WIM
SS
DN
SWM
VV
CTC
Narwhal Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Narwhal Capital Management held 136 positions worth $273M, up 5.8% from $258M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Narwhal Capital Management's Q1 2015 filing shows 8 new, 56 increased, 24 reduced and 12 closed positions. Its largest new stake was Medtronic: 39,175 shares worth $3.06M. The largest sale was Wells Fargo, an estimated $1.73M.
By sector, the portfolio is most concentrated in Materials at 14% of assets, up from 12% a quarter earlier, followed by Miscellaneous and Healthcare.
- Narwhal Capital Management's largest Q1 2015 buy was Medtronic: 39,175 shares worth $3.06M.
- Narwhal Capital Management added most to Exelon in Q1 2015, an estimated $1.99M increase.
- Narwhal Capital Management's biggest Q1 2015 reduction was NextEra Energy, cutting an estimated $1.14M.
- Narwhal Capital Management fully exited Wells Fargo in Q1 2015, selling an estimated $1.73M.
- Narwhal Capital Management's ten largest holdings make up 31% of its $273M portfolio in Q1 2015.
- Narwhal Capital Management opened 8 new positions and closed 12 in Q1 2015.
- Narwhal Capital Management's portfolio value rose 5.8% quarter-over-quarter to $273M.
Based on Narwhal Capital Management's 13F filing for Q1 2015, filed 28 Apr 2015.